CN117085058A - 一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 - Google Patents
一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 Download PDFInfo
- Publication number
- CN117085058A CN117085058A CN202311058337.3A CN202311058337A CN117085058A CN 117085058 A CN117085058 A CN 117085058A CN 202311058337 A CN202311058337 A CN 202311058337A CN 117085058 A CN117085058 A CN 117085058A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- ointment
- treating breast
- breast diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 39
- 208000030270 breast disease Diseases 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 16
- 238000002360 preparation method Methods 0.000 title description 5
- 239000000843 powder Substances 0.000 claims abstract description 63
- 239000008280 blood Substances 0.000 claims abstract description 29
- 210000004369 blood Anatomy 0.000 claims abstract description 29
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims abstract description 25
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims abstract description 25
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims abstract description 25
- 241000239226 Scorpiones Species 0.000 claims abstract description 23
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000011324 bead Substances 0.000 claims abstract description 23
- 235000019438 castor oil Nutrition 0.000 claims abstract description 23
- 239000004359 castor oil Substances 0.000 claims abstract description 23
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 23
- 239000004332 silver Substances 0.000 claims abstract description 23
- 229910052709 silver Inorganic materials 0.000 claims abstract description 23
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 21
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 21
- 229940075397 calomel Drugs 0.000 claims abstract description 21
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims abstract description 21
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 20
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 20
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 20
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 20
- 239000004863 Frankincense Substances 0.000 claims abstract description 20
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 20
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims description 22
- 235000007189 Oryza longistaminata Nutrition 0.000 claims description 20
- 240000007594 Oryza sativa Species 0.000 claims description 20
- 235000007164 Oryza sativa Nutrition 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 2
- 229940100615 topical ointment Drugs 0.000 claims 5
- 239000003814 drug Substances 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 16
- 210000005075 mammary gland Anatomy 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 abstract description 3
- 238000001356 surgical procedure Methods 0.000 abstract description 3
- 238000003723 Smelting Methods 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 206010020718 hyperplasia Diseases 0.000 description 8
- 206010006272 Breast mass Diseases 0.000 description 7
- 239000011505 plaster Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000003200 Adenoma Diseases 0.000 description 2
- 206010001233 Adenoma benign Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000003163 breast adenoma Diseases 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006256 Breast hyperplasia Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种用于治疗乳腺疾病的外敷药膏,按照重量份数计算包括以下各组分:松香300‑500份;黄丹60‑120份;轻粉30‑60份;银珠60‑120份;乳香60‑120份;蓖麻油60‑120份;没药60‑120份;血蝎60‑120份;珍珠粉60‑120份;三七粉60‑120份;本发明与现有技术相比,各个组分相互配合采用中医原理能够有效的对乳腺疾病进行治理,治疗周期相对较短、且基本无副作用大、方便自行使用;且只通过局部贴敷外用即能达到目前医疗市场上必须通过外科手术或使用抗生素等全身治疗才能实现的治疗目的;实现了大病小治,既经济又便捷,值得推广应用。
Description
技术领域
本发明涉及药膏技术领域,具体涉及一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法。
背景技术
乳腺增生病是妇女的一种常见非炎性非肿瘤性疾病,发病率为75%左右,其中约有2%~4%的患者可发生囊性增生而癌变,因此提高本病疗效至关重要。乳腺增生属于中医的“乳癖”范畴,是中青年妇女的常见病、多发病,其发病率居全部乳腺疾病的首位,多见于25~45岁女性,且现在起发病率呈逐年上升趋势,发病人群也逐渐低龄化。
已有治疗乳腺炎症的药种类很多,常用治疗用药多为:西药激素类、抗生素类、中草药口服液等,但是上述药物其治疗周期过长、副作用大、不能方便自行使用等缺陷。
发明内容
针对现有技术中所存在的不足,本发明的目的在于提供一种用于治疗乳腺疾病的外敷药膏,以解决现有技术中,对乳腺疾病治疗的药物存在治疗周期过长、副作用大、不能方便自行使用等问题。
为实现上述目的,本发明采用了如下的技术方案:一种用于治疗乳腺疾病的外敷药膏,按照重量份数计算包括以下各组分:
松香 300-500份;
黄丹 60-120份;
轻粉 30-60份;
银珠 60-120份;
乳香 60-120份;
蓖麻油 60-120份;
没药 60-120份;
血蝎 60-120份;
珍珠粉 60-120份;
三七粉 60-120份。
进一步,按照重量份数计算包括以下各组分:
松香 300份;
黄丹 60份;
轻粉 30份;
银珠 60份;
乳香 60份;
蓖麻油 60份;
没药 60份;
血蝎 60份;
珍珠粉 60份;
三七粉 60份。
进一步,按照重量份数计算包括以下各组分:
松香 500份;
黄丹 120份;
轻粉 60份;
银珠 120份;
乳香 120份;
蓖麻油 120份;
没药 120份;
血蝎 120份;
珍珠粉 120份;
三七粉 120份。
进一步,所述按照重量份数计算包括以下各组分:
松香 400份;
黄丹 90份;
轻粉 45份;
银珠80份;
乳香90份;
蓖麻油 90份;
没药 90份;
血蝎 80份;
珍珠粉 80份;
三七粉 80份。
其中,
松香是一种化学物质,主要成分为松脂,还含有少量的甘油、脂肪酸、矿物质和蛋白质等物质;用于祛风排湿、排脓拔毒、敛疮生肌、祛瘀滞、止血止痛、祛风止痒。
黄丹是一种化学物质,主要成分为硫酸钡,还含有少量的碳酸钙、氢氧化物、硫酸盐和碳酸氢盐等物质;具有生肌、杀虫、止痒的功效,用于治疗湿疹,黄水疮,肌炎等。
轻粉是一种化学物质,主要成分为碳酸钙和硫酸钡,还含有少量的氢氧化物、硫酸盐和碳酸氢盐等物质;用于杀菌、止痒、湿癣等。
银珠是一种化学物质,主要成分为硫酸钡,还含有少量的碳酸钙、氢氧化物、硫酸盐和碳酸氢盐等物质;具有攻毒、杀虫以及除湿等功效。
芘麻油是一种植物油,主要成分为亚油酸和油酸,还含有少量的α-亚麻酸、棕榈酸、硬脂酸等脂肪酸;具有保湿,滋润皮肤,缓解疼痛和瘙痒、红肿等。
乳香是一种树脂,主要来自于橄榄科树木的树脂;用于治疗风湿疼痛、跌打损伤以及痈肿疮毒等。
没药是一种树脂,主要来自于橄榄科树木的树脂;用于收敛溃疡、防斑块的形成。
血蝎是一种动物,属于蝎科;血蝎主要分布在热带和亚热带地区,是一种有毒昆虫,毒性较强;用于消炎、止血生肌、散瘀止痛。
珍珠粉是一种由珍珠贝壳制成的粉末,主要成分为碳酸钙和蛋白质,还含有少量的磷、铁、镁、钾等矿物质和微量元素;用于收敛疮疡、祛瘀除斑。
三七粉是一种中药,主要成分为三七皂苷和多糖等有效成分;用于散瘀止血、消肿定痛。
上述各组分配合后形成的本外敷药膏的治疗机制及作用原理如下:
各组分搭配,相互配伍、相互促进,不但能够发挥每一种药的疗效,而且能够实现药物之间的协同作用,实现单一药物难以达到的效果,从而通过祛风排湿、活血化瘀、去除瘀滞、杀菌消炎等达到促进血液循环、排脓拔毒、祛腐生肌、消肿止痛的效果,最终实现祛除疮痈,消除异常增生包块等的奇特效果。依据“乳腺病始于肝郁、后血瘀痰瘀成块,治宜疏肝理气、活血化瘀、软坚散结”的中医原理对乳腺增生、乳腺腺瘤等乳腺疾病的外敷治疗有药到病除的效果。
本发明还采用了如下的技术方案:一种用于治疗乳腺疾病的外敷药膏的制备方法,包括以下步骤:
称量好各组分,后将松香和蓖麻油在温度为50-60℃下熬制30-40min;
再加入银珠在温度为50-60℃下煨火20-30min,继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;
再将剩余各组分加工成粉末后加入红色米糊状的中间体中搅拌均匀,冷却后制成。
进一步,所述红色米糊状的中间体是将其滴入常温水中,以不沾手、敛起来度量。
本发明还采用了如下的技术方案:一种用于治疗乳腺疾病的外敷药膏的使用方法,包括以下步骤:
将外敷药膏加热,后贴设于患处,且三天更换一次。
进一步,所述外敷药膏置于40-50℃的热水中加热1-1.2min。
相比于现有技术,本发明具有如下有益效果:
1、本用于治疗乳腺疾病的外敷药膏主要由松香、黄丹、轻粉、银珠、乳香、蓖麻油、没药、血蝎、珍珠粉以及三七粉构成,各个组分相互配合采用中医原理能够有效的对乳腺疾病进行治理,治疗周期相对较短、且基本无副作用大、方便自行使用。
2、本用于治疗乳腺疾病的外敷药膏只通过局部贴敷外用即能达到目前医疗市场上必须通过外科手术或使用抗生素等全身治疗才能实现的治疗目的。比如医疗领域对痈、蜂窝织炎、异常增生的乳腺结节、乳腺包块、乳腺腺瘤等都必须以手术切除方式或全身抗生素治疗方式来达到治疗目的,而本用于治疗乳腺疾病的外敷药膏则只局部贴敷即可彻底治愈痈、蜂窝织炎、异常增生的乳腺结节、乳腺包块、乳腺腺瘤等,免除了实施手术和抗生素治疗给病人带来的痛苦,实现了大病小治,既经济又便捷,值得推广应用。
3、本用于治疗乳腺疾病的外敷药膏的制备方法步骤简单,能够使各组分有效的融合在一起,以进行配伍发挥效果。
4、本用于治疗乳腺疾病的外敷药膏的使用方法,仅需敷设至患处且保持三天更换一次,方便自行使用。
具体实施方式
下面通过具体实施方式对本发明作进一步详细的说明:
实施例1
一种用于治疗乳腺疾病的外敷药膏,其具体制备过程如下:
1、称量松香300份、黄丹60份、轻粉30份、银珠60份、乳香60份、蓖麻油60份、没药60份、血蝎60份、珍珠粉60份以及三七粉60份;
2、将松香和蓖麻油加入至炼药炉中熬制30min,炼药炉内的温度控制在50℃;
3、再将银珠加入至炼药炉中煨火20min,且炼药炉内的温度保持在50℃;后继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;达到红色米糊状的中间体的判断方法是将其滴入常温水中,以不沾手、敛起来度量;满足此要求则说明此步骤达到所需目标,来使松香、蓖麻油、银珠与黄丹充分融合,且在加入其它组分后能够有效的进行包覆、融合,则将各个组分的药效充分发挥出来;
4、最后将轻粉、乳香、没药、血蝎、珍珠粉、三七粉细磨成粉末后加入搅拌均匀,直到冷却,膏药即制成。
实施例2
一种用于治疗乳腺疾病的外敷药膏,其具体制备过程如下:
1、称量松香500份、黄丹120份、轻粉60份、银珠120份、乳香120份、蓖麻油120份、没药120份、血蝎120份、珍珠粉120份以及三七粉120份;
2、将松香和蓖麻油加入至炼药炉中熬制40min,炼药炉内的温度控制在60℃;
3、再将银珠加入至炼药炉中煨火30min,且炼药炉内的温度保持在60℃;后继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;达到红色米糊状的中间体的判断方法是将其滴入常温水中,以不沾手、敛起来度量;
4、最后将轻粉、乳香、没药、血蝎、珍珠粉、三七粉细磨成粉末后加入搅拌均匀,直到冷却,膏药即制成。
实施例3
一种用于治疗乳腺疾病的外敷药膏,其具体制备过程如下:
1、称量松香400份、黄丹90份、轻粉45份、银珠80份、乳香90份、蓖麻油90份、没药90份、血蝎80份、珍珠粉80份以及三七粉80份;
2、将松香和蓖麻油加入至炼药炉中熬制35min,炼药炉内的温度控制在55℃;
3、再将银珠加入至炼药炉中煨火25min,且炼药炉内的温度保持在55℃;后继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;达到红色米糊状的中间体的判断方法是将其滴入常温水中,以不沾手、敛起来度量;
4、最后将轻粉、乳香、没药、血蝎、珍珠粉、三七粉细磨成粉末后加入搅拌均匀,直到冷却,膏药即制成。
实施例4
一种用于治疗乳腺疾病的外敷药膏,其具体制备过程如下:
1、称量松香360份、黄丹73份、轻粉40份、银珠69份、乳香70份、蓖麻油70份、没药80份、血蝎70份、珍珠粉70份以及三七粉70份;
2、将松香和蓖麻油加入至炼药炉中熬制33min,炼药炉内的温度控制在52℃;
3、再将银珠加入至炼药炉中煨火22min,且炼药炉内的温度保持在52℃;后继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;达到红色米糊状的中间体的判断方法是将其滴入常温水中,以不沾手、敛起来度量;
4、最后将轻粉、乳香、没药、血蝎、珍珠粉、三七粉细磨成粉末后加入搅拌均匀,直到冷却,膏药即制成。
实施例5
一种用于治疗乳腺疾病的外敷药膏,其具体制备过程如下:
1、称量松香440份、黄丹110份、轻粉50份、银珠106份、乳香108份、蓖麻油110份、没药100份、血蝎110份、珍珠粉106份以及三七粉105份;
2、将松香和蓖麻油加入至炼药炉中熬制38min,炼药炉内的温度控制在57℃;
3、再将银珠加入至炼药炉中煨火26min,且炼药炉内的温度保持在57℃;后继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;达到红色米糊状的中间体的判断方法是将其滴入常温水中,以不沾手、敛起来度量;
4、最后将轻粉、乳香、没药、血蝎、珍珠粉、三七粉细磨成粉末后加入搅拌均匀,直到冷却,膏药即制成。
上述实施例1-实施例5制备的一种用于治疗乳腺疾病的外敷药膏在使用时,具体方法如下:
将本用于治疗乳腺疾病的外敷药膏放置到40-50℃的热水中加热1-1.2min,来使其具有一定的软度和粘性,后将其贴设于患处;在此过程中三天更换一次,因三天左右本用于治疗乳腺疾病的外敷药膏中的药效能够充分被吸收;1-3月为一个使用疗程。
目前,本用于治疗乳腺疾病的外敷药膏已在临床医疗中应用达140年之久,历经四代人的传承,现临床治疗病例已达3万人,其中对疮痈的治愈率为100%,对乳腺增生、乳腺包块、乳腺腺瘤的治愈率高达90%,对其他包块的治愈率也在80%以上,对癌前病变的疗效也特别显著,一直以来都得到就诊群众的一致好评。
下面以几个实际案例来进行说明。
案例1
患者包某某,女,79岁,四川省自贡市富顺县某村某组人。该患者因***不明原因出现包块、疼痛,并逐渐发展为团块,坚硬如岩石,不能推动,加之本人不愿外科等手术治疗,经多方寻医问药均不得治,于2023年3月使用本用于治疗乳腺疾病的外敷药膏治疗,贴敷1个月后包块疼痛明显减轻、包块出现软化,团块也明显缩小。贴敷至3个月,疼痛完全消失,包块也消失不见,达到了彻底治愈的效果。
案例2
患者华某某,男,70岁,四川省自贡市富顺县某镇某社区某组人。该患者于2022年8月因***结节、包块疼痛数月,随即行贴敷本用于治疗乳腺疾病的外敷药膏治疗,3个月后病情缓解,一年后治愈。
案例3
患者陈某某,女,76岁,四川省自贡市富顺县某镇某社区某组人。该患者2022年4月因***结节,呈团块样肿大,质地坚硬,活动度小,时隐时痛,于是行贴敷本用于治疗乳腺疾病的外敷药膏进行软坚化结,治疗3个月后缓解,治疗1年后痊愈。
案例4
陈某某,女,56岁,四川省自贡市富顺县某镇某社区某组人。该患者因肝气郁结、肝气不舒导致乳经不畅、腰痛,***血凝成块,出现乳腺增生、胀痛,***等症状,检查乳腺包块活动度好。于2022年6月进行贴敷本用于治疗乳腺疾病的外敷药膏治疗3个月后,胀痛缓解、消失,增生的包块消失,实现完全治愈。
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。
Claims (8)
1.一种用于治疗乳腺疾病的外敷药膏,其特征在于,按照重量份数计算包括以下各组分:
松香 300-500份;
黄丹 60-120份;
轻粉 30-60份;
银珠 60-120份;
乳香 60-120份;
蓖麻油 60-120份;
没药 60-120份;
血蝎 60-120份;
珍珠粉 60-120份;
三七粉 60-120份。
2.根据权利要求1所述的用于治疗乳腺疾病的外敷药膏,其特征在于,按照重量份数计算包括以下各组分:
松香 300份;
黄丹 60份;
轻粉 30份;
银珠 60份;
乳香 60份;
蓖麻油 60份;
没药 60份;
血蝎 60份;
珍珠粉 60份;
三七粉 60份。
3.根据权利要求1所述的用于治疗乳腺疾病的外敷药膏,其特征在于:按照重量份数计算包括以下各组分:
松香 500份;
黄丹 120份;
轻粉 60份;
银珠 120份;
乳香 120份;
蓖麻油 120份;
没药 120份;
血蝎 120份;
珍珠粉 120份;
三七粉 120份。
4.根据权利要求1所述的用于治疗乳腺疾病的外敷药膏,其特征在于:所述按照重量份数计算包括以下各组分:
松香 400份;
黄丹 90份;
轻粉 45份;
银珠 80份;
乳香 90份;
蓖麻油 90份;
没药 90份;
血蝎 80份;
珍珠粉 80份;
三七粉 80份。
5.一种根据权利要求1-4中任一项所述的用于治疗乳腺疾病的外敷药膏的制备方法,其特征在于,包括以下步骤:
称量好各组分,后将松香和蓖麻油在温度为50-60℃下熬制30-40min;
再加入银珠在温度为50-60℃下煨火20-30min,继续加入黄丹搅拌均匀,直至熬制成红色米糊状的中间体;
再将剩余各组分加工成粉末后加入红色米糊状的中间体中搅拌均匀,冷却后制成。
6.根据权利要求5所述的用于治疗乳腺疾病的外敷药膏的制备方法,其特征在于,所述红色米糊状的中间体是将其滴入常温水中,以不沾手、敛起来度量。
7.一种根据权利要求1-4中任一项所述的用于治疗乳腺疾病的外敷药膏的使用方法,其特征在于,包括以下步骤:
将外敷药膏加热,后贴设于患处,且三天更换一次。
8.根据权利要求7所述的用于治疗乳腺疾病的外敷药膏的使用方法,其特征在于,所述外敷药膏置于40-50℃的热水中加热1-1.2min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311058337.3A CN117085058A (zh) | 2023-08-22 | 2023-08-22 | 一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311058337.3A CN117085058A (zh) | 2023-08-22 | 2023-08-22 | 一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117085058A true CN117085058A (zh) | 2023-11-21 |
Family
ID=88771146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311058337.3A Pending CN117085058A (zh) | 2023-08-22 | 2023-08-22 | 一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117085058A (zh) |
-
2023
- 2023-08-22 CN CN202311058337.3A patent/CN117085058A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101310748B (zh) | 一种治疗烧烫伤的软膏 | |
CN101703651B (zh) | 一种治疗糖尿病坏疽的药物 | |
CN101439114B (zh) | 一种治疗烧烫伤的中药及其制备方法 | |
CN117085058A (zh) | 一种用于治疗乳腺疾病的外敷药膏及制备方法和使用方法 | |
CN102846782A (zh) | 治疗烧烫伤的外用中药软膏及制备方法 | |
CN111529602A (zh) | 一种治疗疖疮疔毒的拔毒膏 | |
CN111544523A (zh) | 一种治疗皮肤溃烂的中药组合物及其应用 | |
CN111544514A (zh) | 一种用于治疗烧烫伤的中药膏剂及其制备方法 | |
CN110841017A (zh) | 痔疮粉、痔疮药及制备方法 | |
CN107050298B (zh) | 一种治疗烧烫伤皮损的中药膏的制备方法 | |
CN110812377A (zh) | 一种痤疮治疗修复组合物及其应用 | |
CN104706919A (zh) | 一种治疗体表溃疡的药物组合物 | |
CN103655854A (zh) | 治疗静脉输液致静脉炎的外敷药及使用方法 | |
CN112603958B (zh) | 一种治疗肌筋膜炎的中药组合物及其制备方法与应用 | |
CN103611007A (zh) | 一种药膏及其制备方法 | |
CN111743965B (zh) | 一种以再生硅治疗痔疮和溃疡的药物 | |
CN108245577B (zh) | 一种烧伤止痛消肿生肌液膏及其制备方法 | |
CN107050302A (zh) | 治疗烧烫伤的外用中药 | |
CN1236798C (zh) | 一种治疗骨结核的外敷药物 | |
CN106620100A (zh) | 修肤软膏及其制备方法 | |
CN102319315A (zh) | 一种治疗乳腺疾病的中药膏 | |
CN104971162A (zh) | 一种烧伤药膏及其制备方法 | |
CN112933169A (zh) | 一种用于治疗慢性创面的中药配伍组分 | |
CN110772579A (zh) | 一种治疗软组织损伤的中药草本组合物及其制备方法 | |
CN104306772A (zh) | 一种治疗放射性皮炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |